Keyphrases
Robot-assisted Radical Prostatectomy
97%
Japan
95%
Multicenter Cohort Study
74%
Metastatic Renal Cell Carcinoma (mRCC)
57%
Biochemical Recurrence
29%
Biochemical Recurrence-free Survival
28%
Molecular Targeted Therapy
28%
Bone Metastasis
28%
Prostate Cancer
24%
Prostate
23%
Risk Factors
23%
Patients with Prostate Cancer
22%
Oncological Outcomes
21%
Predictive Factors
21%
Robot-assisted Laparoscopic Radical Prostatectomy
19%
Sunitinib
19%
Metastasis
17%
Overall Survival
17%
First-line Therapy
16%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
15%
Multi-institutional
15%
Older Men
15%
Seminal Vesicle
15%
International Metastatic Renal Cell Carcinoma Database Consortium
15%
Tumor
15%
Human-following Robot
15%
High Risk
15%
Prostate Cancer Patients
14%
Positive Surgical Margin
14%
Carcinoma of the Penis
14%
Glans
14%
Memorial Sloan-Kettering Cancer Center
14%
Dutasteride
14%
Continuation Rate
14%
Nocardia
14%
No Evidence of Disease
14%
Clinical Practice
14%
Metastasectomy
14%
Targeted Surgery
14%
Benign Prostatic Hyperplasia
14%
Abiraterone Acetate
14%
C-reactive Protein to Albumin Ratio
14%
Group Model
14%
Prostatic Abscess
14%
Intravascular Large B-cell Lymphoma (IVLBCL)
14%
Nomogram
14%
Axitinib
14%
Pathology Report
14%
Prednisolone
14%
Clinical Factors
14%
Medicine and Dentistry
Robot-Assisted Prostatectomy
100%
Prostate Cancer
79%
Cohort Analysis
74%
Biochemical Recurrence Free Survival
30%
Kidney Metastasis
28%
Molecularly Targeted Therapy
28%
Bone Metastasis
28%
Clear Cell Renal Cell Carcinoma
27%
Biochemical Recurrence
26%
Seminal Vesicle
22%
Disease
22%
Predictive Factor
21%
Surgical Margin
20%
Gleason Score
20%
Metastatic Carcinoma
17%
Overall Survival
17%
Retrospective Study
15%
C Reactive Protein
14%
Metastasectomy
14%
Carcinoma
14%
Abiraterone Acetate
14%
Cystectomy
14%
Nocardia
14%
Acute Kidney Injury
14%
Abscess
14%
Large-Cell Lymphoma
14%
Phallus
14%
Cancer
14%
Prednisolone
14%
Denosumab
14%
Androgen
14%
Lung
14%
Prostate Specific Antigen
14%
Biopsy Technique
13%
Malignant Neoplasm
13%
Prednisone
12%
Prognostic Factor
12%
Lymph Node
11%
Partial Nephrectomy
11%
Diffuse Large B-Cell Lymphoma
10%
Neoplasm
10%
Continence
9%
Cytokine Therapy
9%
Nephrectomy
9%
Lymphovascular Invasion
9%
Multivariate Analysis
9%
Kidney Function
8%
Intermediate Risk Population
8%
Pelvis
8%
Retroperitoneal Lymph Node Dissection
8%